title: Molecular pathways: niches in metastatic dormancy.
abstract: Despite the best available treatments for primary tumors, cancer can return, even after a long disease-free interval. During this period, cancer cells are believed to lie dormant in either primary sites, metastatic sites, or independent sites like bone marrow, effectively escaping adjuvant cytotoxic treatments. To date, little is known about how these cells transition to dormancy, or how they are reactivated if cancer recurs. Recent studies have revealed the effects of tumor microenvironment or niche on the regulation of tumor dormancy via the signaling pathways of growth arrest-specific 6, bone morphogenetic protein 7, and TGFβ1, and that the balance between activation of p38 MAPK and ERK MAPK plays a pivotal role in tumor dormancy. In this review, we discuss tumor dormancy from the perspective of the niche and consider potential therapeutic targets. Greater understanding of the mechanisms involved will help guide innovation in the care of patients with advanced cancer.
authors.affiliation: Authors' Affiliation: Department of Periodontics and Oral Medicine, University of Michigan School of Dentistry, Ann Arbor, Michigan.
authors.forename: Kenji
authors.initials: K
authors.lastname: Yumoto
authors.affiliation: Authors' Affiliation: Department of Periodontics and Oral Medicine, University of Michigan School of Dentistry, Ann Arbor, Michigan.
authors.forename: Matthew R
authors.initials: MR
authors.lastname: Eber
authors.affiliation: Authors' Affiliation: Department of Periodontics and Oral Medicine, University of Michigan School of Dentistry, Ann Arbor, Michigan.
authors.forename: Janice E
authors.initials: JE
authors.lastname: Berry
authors.affiliation: Authors' Affiliation: Department of Periodontics and Oral Medicine, University of Michigan School of Dentistry, Ann Arbor, Michigan rtaich@umich.edu shiozawa@umich.edu.
authors.forename: Russell S
authors.initials: RS
authors.lastname: Taichman
authors.affiliation: Authors' Affiliation: Department of Periodontics and Oral Medicine, University of Michigan School of Dentistry, Ann Arbor, Michigan.
authors.forename: Yusuke
authors.initials: Y
authors.lastname: Shiozawa
mesh_terms: D000818:Animals; D006801:Humans; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000378:metabolism* / Q000473:pathology*; D012106:Research; D015398:Signal Transduction; D059016:Tumor Microenvironment
references.citation: Cancer Biol Ther. 2010 Nov 15;10(10):1009-18
references.pmid: 20818175
references.citation: Proc Natl Acad Sci U S A. 2000 Aug 29;97(18):10026-31
references.pmid: 10944199
references.citation: Breast Cancer Res Treat. 2003 Dec;82(3):199-206
references.pmid: 14703067
references.citation: Exp Cell Res. 2013 Jul 1;319(11):1679-86
references.pmid: 23707205
references.citation: Cancer Res. 2008 Aug 1;68(15):6241-50
references.pmid: 18676848
references.citation: Nat Genet. 2012 Jul 01;44(8):852-60
references.pmid: 22751098
references.citation: J Cell Biol. 1999 Oct 4;147(1):89-104
references.pmid: 10508858
references.citation: Proc Natl Acad Sci U S A. 2007 Jun 12;104(24):10063-8
references.pmid: 17553962
references.citation: Nat Rev Immunol. 2006 Feb;6(2):93-106
references.pmid: 16491134
references.citation: Cell. 2012 Aug 17;150(4):764-79
references.pmid: 22901808
references.citation: J Exp Med. 2011 Dec 19;208(13):2641-55
references.pmid: 22124112
references.citation: Ann Surg Oncol. 2012 Jul;19 Suppl 3:S500-8
references.pmid: 21842265
references.citation: Nat Med. 2010 Jan;16(1):116-22
references.pmid: 20023634
references.citation: Nat Biotechnol. 2013 Sep;31(9):775-6
references.pmid: 24022140
references.citation: PLoS One. 2013 Apr 24;8(4):e61873
references.pmid: 23637920
references.citation: Nature. 2012 Oct 18;490(7420):355-60
references.pmid: 23023126
references.citation: Proc Natl Acad Sci U S A. 2006 Apr 11;103(15):5799-804
references.pmid: 16585512
references.citation: Mol Cancer Ther. 2011 Oct;10(10):1763-73
references.pmid: 21933973
references.citation: Nat Rev Clin Oncol. 2009 Jun;6(6):339-51
references.pmid: 19399023
references.citation: J Clin Invest. 2006 May;116(5):1195-201
references.pmid: 16670760
references.citation: Am J Pathol. 2005 Mar;166(3):901-11
references.pmid: 15743801
references.citation: Clin Sci (Lond). 2012 Apr;122(8):361-8
references.pmid: 22187964
references.citation: Proc Natl Acad Sci U S A. 2000 Oct 24;97(22):12260-5
references.pmid: 11050245
references.citation: Exp Hematol. 2012 Sep;40(9):685-94
references.pmid: 22640993
references.citation: Neoplasia. 2010 Feb;12(2):192-205
references.pmid: 20126477
references.citation: Cancer Res. 2010 Feb 15;70(4):1544-54
references.pmid: 20145120
references.citation: Cancer Metastasis Rev. 2012 Dec;31(3-4):429-40
references.pmid: 22699312
references.citation: Blood. 2007 Jul 1;110(1):82-90
references.pmid: 17360942
references.citation: Mol Biol Cell. 2001 Apr;12(4):863-79
references.pmid: 11294892
references.citation: Cancer. 2011 Feb 15;117(4):734-43
references.pmid: 20922806
references.citation: Exp Hematol. 2010 Feb;38(2):132-40
references.pmid: 19922767
references.citation: Blood Cells. 1978;4(1-2):7-25
references.pmid: 747780
references.citation: Oncogene. 2011 Mar 24;30(12):1436-48
references.pmid: 21057535
references.citation: J Cell Biol. 2005 Jul 4;170(1):81-90
references.pmid: 15983059
references.citation: Neoplasia. 2010 Feb;12(2):116-27
references.pmid: 20126470
references.citation: Cancer Res. 2003 Apr 1;63(7):1684-95
references.pmid: 12670923
references.citation: Eur J Cancer. 2010 May;46(7):1181-8
references.pmid: 20304630
references.citation: Cancer Res. 2008 Nov 15;68(22):9157-66
references.pmid: 19010887
references.citation: Cancer Res. 2010 Jul 15;70(14):5706-16
references.pmid: 20570886
references.citation: J Natl Cancer Inst. 2012 Sep 5;104(17):1306-19
references.pmid: 22911670
references.citation: Cancer Biol Ther. 2009 Apr;8(7):618-26
references.pmid: 19252414
references.citation: J Cell Biochem. 2008 Oct 1;105(2):370-80
references.pmid: 18636554
references.citation: Nat Cell Biol. 2013 Jul;15(7):807-17
references.pmid: 23728425
references.citation: J Clin Invest. 2011 Apr;121(4):1298-312
references.pmid: 21436587
references.citation: Oncogene. 2010 Sep 23;29(38):5254-64
references.pmid: 20603615
references.citation: J Natl Cancer Inst. 2007 Feb 21;99(4):309-21
references.pmid: 17312308
references.citation: Blood. 2005 Apr 1;105(7):2631-9
references.pmid: 15585658
references.citation: Clin Cancer Res. 2009 Jan 15;15(2):677-83
references.pmid: 19147774
references.citation: Clin Cancer Res. 2009 Jul 15;15(14):4742-9
references.pmid: 19567592
references.citation: Biol Cell. 2010 Jan;103(1):21-33
references.pmid: 20977427